Akèy › Kansè pwostat rezistan a kastasyon › Oregon
Etid klinik pou Kansè pwostat rezistan a kastasyon nan Oregon
3 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan Oregon.
Tèks ofisyèl etid la (Anglè)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Oregon Urology Institute, Springfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- VA Portland Health Care System, Portland
- Oregon Urology Institute, Springfield
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.